Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Although visual results after use of the new surgical method of retinal endovascular lysis (REVL) seem encouraging,1,2 its effectiveness has not been proved in a controlled, prospective clinical trial. From a histological postmortem study of eyes with central retinal vein occlusion (CRVO), it is still questionable whether an older thrombus can be dissolved using recombinant tissue plasminogen activator (rt-PA).3 We report on the histopathological findings in a human eye 9 months after REVL.
We report the case of a 62-year-old woman having a 7-week-old, highly ischaemic CRVO in her left eye with hand movement vision. Although we were concerned about treating …
Competing interests: None.
The necessary ethics committee approval was secured for this study from the ethics committee of the University of Freiburg, Elsaesser Strasse 2m, Haus 1A, D-79110 Freiburg, Germany.